Abilify Maintena 400 Mg
Product from Canada
Abilify Maintena
Manufactured by: otsuka canada pharma inc
From $599.99 USD per Vial(s)
CAN NOT BE SPLIT Must be taken in existing form.
PRESCRIPTION REQUIRED
Product from Canada
No Generic Alternative Available
No generic alternative is available for this drug.
What is a Generic in Canada? Health Canada (the Canadian regulatory board) evaluates every Canadian generic for their safety, effectiveness, and quality. Every generic used in Canada has the same medical ingredients as their brand name counterpart and is considered bioequivalent to the brand name medication. The quality standards for brand name drugs and generic drugs are the same. All of the ingredients, facilities, and manufacturing processes must meet Canadian federal guidelines for Good Manufacturing Practices. In addition, Canadian generic manufacturers must perform 'comparative bioavailability' studies to demonstrate that their generic products deliver the same amount of medicinal ingredient at the same rate as the brand name medication. Nearly 45% of all prescriptions filled in Canada use generic medication and some hospitals exclusively use generic drugs. For more information, please visit http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/med-gen-eng.php
Vial: ABILIFY MAINTENA is available in two dosage strengths, 300 mg and 400 mg and is provided as a lyophilized powder for reconstitution. One carton contains one vial of powder, one vial of solvent (sterile water for injection), one 3 mL sterile syringe with a 21 gauge needle for reconstitution, one sterile syringe without needle, one 1.5-inch (38 mm) 22 gauge sterile safety needle, one 2-inch (51 mm) 21 gauge sterile safety needle, one 1-inch (25 mm) 23 gauge hypodermic safety needle with needle protection device and one vial adapter.